Ecolab Q3 adjusted EPS rises 13% to $2.07; reported EPS falls 21% on prior-year gain
Ecolab reported third-quarter 2025 net sales of $4.2 billion, up 4%, and adjusted diluted EPS of $2.07, up 13%. Reported diluted EPS fell 21% to $2.05 because the year-earlier quarter included a gain on the sale of its global surgical solutions business. The company sharpened its 2025 adjusted EPS outlook to $7.48 to $7.58, growth of 12% to 14%, which matters to shareholders because it sets the company's current full-year earnings range.
Key points
- Q3 2025 net sales $4,165.0 million, up 4%; organic sales up 3%
- Reported diluted EPS $2.05 vs. $2.58 a year ago (down 21%); adjusted diluted EPS $2.07 vs. $1.83 (up 13%)
- 2025 adjusted EPS outlook sharpened to $7.48 to $7.58; fourth-quarter adjusted EPS expected at $2.02 to $2.12
- Expected 2025 special charges of about $0.34 per share, mainly restructuring
The filing
Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 28, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.